Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganetespib in Advanced GIST
NCT01039519Phase 2Completed
- Sponsor
- Synta Pharmaceuticals Corp.
- Start
- Jan 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ganetespib in gastrointestinal stromal tumor (GIST), sponsored by Synta Pharmaceuticals Corp.. Started Jan 2010; status: completed.
02
Drugs
ganetespib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT01039519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01039519.